Metformin activates a duodenal Ampk–dependent pathway to lower hepatic glucose production in rats
Nature Medicine2015Vol. 21(5), pp. 506–511
Citations Over TimeTop 1% of 2015 papers
Frank A. Duca, Clémence D. Côté, Brittany A. Rasmussen, Melika Zadeh‐Tahmasebi, Guy A. Rutter, B Filippi, Tony K.T. Lam
Related Papers
- → Metformin – its potential anti-cancer and anti-aging effects(2017)199 cited
- → Exogenous Glucocorticoids and a High-Fat Diet Cause Severe Hyperglycemia and Hyperinsulinemia and Limit Islet Glucose Responsiveness in Young Male Sprague-Dawley Rats(2013)47 cited
- → The Effect of Fasting on Tissue Cyclic cAMP and Plasma Glucagon in the Obese Hyperglycemic Mouse(1975)39 cited
- → Normoglycemia sensitizes MDA‐MB‐231 breast cancer cells to metformin through an AMPK‐dependent mechanism (LB610)(2014)2 cited
- Beneficial effects of metformin on primary cardiomyocytes via activation of adenosine monophosphate-activated protein kinase(2011)